Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices
04 janv. 2022 09h00 HE
|
Syapse
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
Syapse Recognized by Comparably Awards Across Four Categories
17 déc. 2021 10h00 HE
|
Syapse
SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
Bayhealth Collaborates with Syapse, Bringing Data-Driven Approach to Oncology Care
15 déc. 2021 10h00 HE
|
Syapse
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
Syapse Announces New Studies Published at Virtual ISPOR Europe 2021
06 déc. 2021 11h00 HE
|
Syapse
SAN FRANCISCO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Syapse Senior People Manager Recognized as 2021 WellBeyond Leader of the Year for Emerging Companies While the Company Takes Home Three Comparably Awards
13 oct. 2021 09h00 HE
|
Syapse
SAN FRANCISCO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
Syapse Enters Real-World Data Collaboration with Merck to Inform and Improve Cancer Care
06 oct. 2021 09h00 HE
|
Syapse
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
Study of Cancer Patients and COVID-19 Highlights Health Disparities
22 juil. 2021 08h30 HE
|
Syapse
DETROIT, July 22, 2021 (GLOBE NEWSWIRE) -- Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and...
Syapse Announces New Real-World Data Studies Published at 2021 American Society for Clinical Oncology Annual Meeting
03 juin 2021 09h00 HE
|
Syapse
SAN FRANCISCO, June 03, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
Syapse Showcases Real-World Mortality Data in American Society of Clinical Oncology’s JCO-CCI
09 avr. 2021 09h00 HE
|
Syapse
SAN FRANCISCO, April 09, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today...
Syapse Expands Strategic Collaboration with Pfizer Focusing on Real-World Evidence
10 mars 2021 10h00 HE
|
Syapse
Through the Syapse Learning Health Network™, Pfizer will Generate Insights to Advance Cancer Outcomes Research SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world...